# Payoneer Global Inc.: financial statements, quarterly

PAYO · Nasdaq · CIK 1845815 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/payo.md) · [Financials](/companies/payo/financials.md) · [Filings](/companies/payo/filings.md) · [Insiders](/companies/payo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/payo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [145](/filings/0001558370-24-014423.md) | [157 d](/filings/0001104659-26-020487.md) | [160](/filings/0001558370-25-006729.md) | [171](/filings/0001558370-25-010514.md) | [180](/filings/0001104659-25-106987.md) | [198 d](/filings/0001104659-26-020487.md) | [186](/filings/0001104659-26-057109.md) | [200](/filings/0001104659-26-091988.md) | [210](/filings/0001104659-25-106987.md) | [217 d](/filings/0001104659-26-020487.md) | [208](/filings/0001104659-26-057109.md) | [220](/filings/0001104659-26-091988.md) |
| Research and development | $m | [27.0](/filings/0001558370-24-014423.md) | [35.0 d](/filings/0001104659-26-020487.md) | [32.1](/filings/0001558370-25-006729.md) | [27.6](/filings/0001558370-25-010514.md) | [34.6](/filings/0001104659-25-106987.md) | [40.4 d](/filings/0001104659-26-020487.md) | [37.3](/filings/0001104659-26-057109.md) | [37.4](/filings/0001104659-26-091988.md) | [39.9](/filings/0001104659-25-106987.md) | [40.9 d](/filings/0001104659-26-020487.md) | [43.3](/filings/0001104659-26-057109.md) | [47.0](/filings/0001104659-26-091988.md) |
| Operating income | $m | [29.5](/filings/0001558370-24-014423.md) | [25.7 d](/filings/0001104659-26-020487.md) | [38.4](/filings/0001558370-25-006729.md) | [46.3](/filings/0001558370-25-010514.md) | [35.2](/filings/0001104659-25-106987.md) | [29.2 d](/filings/0001104659-26-020487.md) | [29.3](/filings/0001104659-26-057109.md) | [30.1](/filings/0001104659-26-091988.md) | [36.3](/filings/0001104659-25-106987.md) | [28.9 d](/filings/0001104659-26-020487.md) | [30.0](/filings/0001104659-26-057109.md) | [16.9](/filings/0001104659-26-091988.md) |
| Income tax | $m | [10.0](/filings/0001558370-24-014423.md) | [14.3 d](/filings/0001104659-26-020487.md) | [13.9](/filings/0001558370-25-006729.md) | [15.9](/filings/0001558370-25-010514.md) | [(19.5)](/filings/0001104659-25-106987.md) | [8.0 d](/filings/0001104659-26-020487.md) | [7.2](/filings/0001104659-26-057109.md) | [10.4](/filings/0001104659-26-091988.md) | [16.4](/filings/0001104659-25-106987.md) | [8.4 d](/filings/0001104659-26-020487.md) | [9.6](/filings/0001104659-26-057109.md) | [8.7](/filings/0001104659-26-091988.md) |
| Net income | $m | [12.8](/filings/0001558370-24-014423.md) | [27.0 d](/filings/0001104659-26-020487.md) | [29.0](/filings/0001558370-25-006729.md) | [32.4](/filings/0001558370-25-010514.md) | [41.6](/filings/0001104659-25-106987.md) | [18.2 d](/filings/0001104659-26-020487.md) | [20.6](/filings/0001104659-26-057109.md) | [19.5](/filings/0001104659-26-091988.md) | [14.1](/filings/0001104659-25-106987.md) | [19.0 d](/filings/0001104659-26-020487.md) | [19.6](/filings/0001104659-26-057109.md) | [(2.4)](/filings/0001104659-26-091988.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001558370-24-014423.md) | not reported | [0.08](/filings/0001558370-25-006729.md) | [0.09](/filings/0001558370-25-010514.md) | [0.11](/filings/0001104659-25-106987.md) | not reported | [0.05](/filings/0001104659-26-057109.md) | [0.05](/filings/0001104659-26-091988.md) | [0.04](/filings/0001104659-25-106987.md) | not reported | [0.06](/filings/0001104659-26-057109.md) | [(0.01)](/filings/0001104659-26-091988.md) |
| Basic EPS | $ per share | [0.04](/filings/0001558370-24-014423.md) | not reported | [0.08](/filings/0001558370-25-006729.md) | [0.09](/filings/0001558370-25-010514.md) | [0.12](/filings/0001104659-25-106987.md) | not reported | [0.06](/filings/0001104659-26-057109.md) | [0.05](/filings/0001104659-26-091988.md) | [0.04](/filings/0001104659-25-106987.md) | not reported | [0.06](/filings/0001104659-26-057109.md) | [(0.01)](/filings/0001104659-26-091988.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [591](/filings/0001558370-24-014423.md) | [617](/filings/0001104659-26-020487.md) | [587](/filings/0001558370-25-006729.md) | [576](/filings/0001558370-25-010514.md) | [534](/filings/0001104659-25-106987.md) | [497](/filings/0001104659-26-020487.md) | [524](/filings/0001104659-26-057109.md) | [497](/filings/0001104659-26-091988.md) | [479](/filings/0001104659-25-106987.md) | [416](/filings/0001104659-26-091988.md) | [339](/filings/0001104659-26-057109.md) | [346](/filings/0001104659-26-091988.md) |
| Current assets | $m | [6,061](/filings/0001558370-23-018263.md) | [7,109](/filings/0001558370-25-001804.md) | [6,616](/filings/0001558370-24-007336.md) | [6,733](/filings/0001558370-24-011345.md) | [6,249](/filings/0001558370-24-014423.md) | [7,100](/filings/0001104659-26-020487.md) | [6,713](/filings/0001558370-25-006729.md) | [7,213](/filings/0001558370-25-010514.md) | [7,401](/filings/0001104659-25-106987.md) | [8,111](/filings/0001104659-26-091988.md) | [7,723](/filings/0001104659-26-057109.md) | [7,960](/filings/0001104659-26-091988.md) |
| Total assets | $m | [6,218](/filings/0001558370-23-018263.md) | [7,283](/filings/0001558370-25-001804.md) | [6,795](/filings/0001558370-24-007336.md) | [6,920](/filings/0001558370-24-011345.md) | [7,051](/filings/0001558370-24-014423.md) | [7,930](/filings/0001104659-26-020487.md) | [7,550](/filings/0001558370-25-006729.md) | [8,110](/filings/0001558370-25-010514.md) | [8,205](/filings/0001104659-25-106987.md) | [8,957](/filings/0001104659-26-091988.md) | [8,598](/filings/0001104659-26-057109.md) | [8,765](/filings/0001104659-26-091988.md) |
| Current liabilities | $m | [5,511](/filings/0001558370-23-018263.md) | [6,542](/filings/0001558370-25-001804.md) | [6,060](/filings/0001558370-24-007336.md) | [6,191](/filings/0001558370-24-011345.md) | [6,263](/filings/0001558370-24-014423.md) | [7,131](/filings/0001104659-26-020487.md) | [6,731](/filings/0001558370-25-006729.md) | [7,208](/filings/0001558370-25-010514.md) | [7,308](/filings/0001104659-25-106987.md) | [8,084](/filings/0001104659-26-091988.md) | [7,762](/filings/0001104659-26-057109.md) | [7,937](/filings/0001104659-26-091988.md) |
| Total liabilities | $m | [5,580](/filings/0001558370-23-018263.md) | [6,619](/filings/0001558370-25-001804.md) | [6,134](/filings/0001558370-24-007336.md) | [6,251](/filings/0001558370-24-011345.md) | [6,323](/filings/0001558370-24-014423.md) | [7,206](/filings/0001104659-26-020487.md) | [6,799](/filings/0001558370-25-006729.md) | [7,340](/filings/0001558370-25-010514.md) | [7,455](/filings/0001104659-25-106987.md) | [8,252](/filings/0001104659-26-091988.md) | [7,939](/filings/0001104659-26-057109.md) | [8,111](/filings/0001104659-26-091988.md) |
| Long-term debt | $m | [15.8](/filings/0001558370-23-018263.md) | [18.4](/filings/0001558370-24-007336.md) | [14.4](/filings/0001558370-24-007336.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [638](/filings/0001558370-24-014423.md) | [664](/filings/0001104659-26-020487.md) | [662](/filings/0001558370-25-010514.md) | [669](/filings/0001104659-25-106987.md) | [728](/filings/0001104659-25-106987.md) | [725](/filings/0001104659-26-091988.md) | [751](/filings/0001104659-26-091988.md) | [771](/filings/0001104659-26-091988.md) | [750](/filings/0001104659-25-106987.md) | [704](/filings/0001104659-26-091988.md) | [659](/filings/0001104659-26-091988.md) | [654](/filings/0001104659-26-091988.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [41.4 d](/filings/0001558370-24-014423.md) | [58.2 d](/filings/0001104659-26-020487.md) | [39.5](/filings/0001558370-25-006729.md) | [41.4 d](/filings/0001558370-25-010514.md) | [50.1 d](/filings/0001104659-25-106987.md) | [45.9 d](/filings/0001104659-26-020487.md) | [53.7](/filings/0001104659-26-057109.md) | [70.7 d](/filings/0001104659-26-091988.md) | [54.2 d](/filings/0001104659-25-106987.md) | [54.9 d](/filings/0001104659-26-020487.md) | [51.8](/filings/0001104659-26-057109.md) | [61.2 d](/filings/0001104659-26-091988.md) |
| Capital expenditure | $m | [1.9 d](/filings/0001558370-24-014423.md) | [4.1 d](/filings/0001104659-26-020487.md) | [1.6](/filings/0001558370-25-006729.md) | [1.2 d](/filings/0001558370-25-010514.md) | [1.6 d](/filings/0001104659-25-106987.md) | [3.7 d](/filings/0001104659-26-020487.md) | [4.7](/filings/0001104659-26-057109.md) | [2.6 d](/filings/0001104659-26-091988.md) | [5.0 d](/filings/0001104659-25-106987.md) | [14.6 d](/filings/0001104659-26-020487.md) | [10.1](/filings/0001104659-26-057109.md) | [11.0 d](/filings/0001104659-26-091988.md) |
| Share repurchases | $m | [17.3 d](/filings/0001558370-24-014423.md) | [21.0 d](/filings/0001104659-26-020487.md) | [51.0](/filings/0001558370-25-006729.md) | [47.7 d](/filings/0001558370-25-010514.md) | [21.8 d](/filings/0001104659-25-106987.md) | [17.1 d](/filings/0001104659-26-020487.md) | [17.8](/filings/0001104659-26-057109.md) | [32.0 d](/filings/0001104659-26-091988.md) | [45.3 d](/filings/0001104659-25-106987.md) | [78.6 d](/filings/0001104659-26-020487.md) | [75.0](/filings/0001104659-26-057109.md) | [17.7 d](/filings/0001104659-26-091988.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [350](/filings/0001558370-23-018263.md) | [388](/filings/0001558370-24-007336.md) | [388](/filings/0001558370-24-011345.md) | [382](/filings/0001558370-24-014423.md) | [379](/filings/0001558370-25-006729.md) | [373](/filings/0001558370-25-010514.md) | [374](/filings/0001104659-25-106987.md) | [382](/filings/0001104659-26-057109.md) | [381](/filings/0001104659-26-091988.md) | [378](/filings/0001104659-25-106987.md) | [350](/filings/0001104659-26-057109.md) | [337](/filings/0001104659-26-091988.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 338,850,836 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-091988.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.